Accelerated LBBP for Patients With RHF and Severe TR (NCT07470047) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Accelerated LBBP for Patients With RHF and Severe TR
China24 participantsStarted 2026-03-10
Plain-language summary
This study is a prospective, single-arm, target value clinical trial. We plan to prospectively enroll and follow 24 patients across three centers nationwide who have a low baseline heart rate (HR ≤ 60 bpm), meet the indication for permanent pacemaker implantation, and have right-sided heart failure with severe or greater tricuspid regurgitation. All patients will undergo pacemaker implantation using left bundle branch pacing (LBBP), and the pacing rate will be uniformly increased to 90 bpm (reduced to 80-85 bpm in case of intolerance). Patients will be followed for 6 months to evaluate the effects of heart-rate increase on hemodynamics, heart failure symptoms, and physical function in patients with right-sided heart failure.
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Mean resting heart rate ≤ 65 beats/min (based on a resting electrocardiogram).
✓. Clinically confirmed right-sided heart failure, requiring ≥2 diuretic units to fully control edema, or having persistent grade ≥1 edema despite diuretic therapy.
✓. Echocardiography shows severe or greater tricuspid regurgitation.
✓. With/without an indication for permanent pacemaker implantation.
✓. Is able to understand the purpose of the trial, voluntarily participates and signs written informed consent, and is willing to complete follow-up visits as required by the protocol.
Exclusion criteria
✕. Mean pulmonary artery pressure (mPAP) \> 35 mmHg measured by right heart catheterization at a pacing rate of 60 bpm.
✕. Left ventricular ejection fraction (LVEF) \< 50% or left ventricular end-diastolic diameter (LVEDD) \> 56 mm as measured by echocardiography.
✕. Prior implantation of a cardiac pacemaker.
✕. Moderate or greater left-sided valvular regurgitation or stenosis.
✕
What they're measuring
1
An increase of ≥10 points in the Kansas City Cardiomyopathy Questionnaire (KCCQ) score at the 6-month follow-up compared with baseline.
Timeframe: From enrollment to the 6-month follow-up